MeSH term
Frequency | Condition_Probility | Cell Division | 6 | 0.0 |
Cells, Cultured | 22 | 0.0 |
DNA, Complementary | 3 | 0.0 |
Gene Library | 2 | 0.0 |
Humans | 187 | 0.0 |
Phenotype | 5 | 0.0 |
Animals | 82 | 0.0 |
Antibodies, Monoclonal/immunology | 9 | 0.0 |
Antibodies, Viral/*immunology | 2 | 4.0 |
Antigens, CD/*immunology | 3 | 0.0 |
Epitopes/immunology | 3 | 0.0 |
Genotype | 7 | 0.0 |
*Membrane Proteins | 56 | 5.0 |
Research Support, U.S. Gov't, P.H.S. | 71 | 0.0 |
Hela Cells | 7 | 0.0 |
Transfection | 17 | 0.0 |
Cell Line | 46 | 0.0 |
Fetal Blood/cytology | 2 | 1.0 |
*Membrane Glycoproteins | 18 | 2.0 |
Multigene Family | 2 | 0.0 |
Precipitin Tests | 12 | 0.0 |
Protein Binding/drug effects | 3 | 0.0 |
Aged | 13 | 0.0 |
Fatal Outcome | 2 | 0.0 |
Female | 28 | 0.0 |
Adolescent | 7 | 0.0 |
Adult | 17 | 0.0 |
Amino Acid Sequence | 32 | 0.0 |
B-Lymphocytes/*immunology | 5 | 0.0 |
Binding, Competitive | 3 | 0.0 |
Child, Preschool | 4 | 0.0 |
Hepacivirus/immunology | 3 | 16.0 |
Hepatitis C/immunology | 2 | 20.0 |
Middle Aged | 18 | 0.0 |
Molecular Sequence Data | 38 | 0.0 |
Research Support, Non-U.S. Gov't | 130 | 0.0 |
Antigens, CD/biosynthesis/*immunology | 2 | 10.0 |
Autoimmunity | 2 | 1.0 |
Biological Markers | 2 | 0.0 |
Hepacivirus/*immunology | 5 | 16.0 |
Male | 33 | 0.0 |
Prognosis | 3 | 0.0 |
Antigens, CD/*chemistry/genetics/*metabolism | 2 | 25.0 |
CHO Cells | 5 | 0.0 |
Detergents | 2 | 1.0 |
Hamsters | 10 | 0.0 |
Macromolecular Substances | 12 | 0.0 |
Membrane Proteins/chemistry/genetics/*metabolism | 2 | 3.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Antigens, CD/immunology/*metabolism | 5 | 10.0 |
Flow Cytometry | 16 | 0.0 |
Hepacivirus/pathogenicity | 2 | 28.0 |
Immunoprecipitation | 2 | 0.0 |
RNA, Viral/blood/metabolism | 2 | 66.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Viral Envelope Proteins/immunology/*metabolism | 3 | 42.0 |
Child | 5 | 0.0 |
Phosphorylation | 8 | 0.0 |
Protein Binding/immunology | 2 | 1.0 |
Signal Transduction/*immunology | 4 | 1.0 |
Tyrosine/metabolism | 4 | 0.0 |
Antibodies, Monoclonal/pharmacology | 5 | 0.0 |
Cell Adhesion/drug effects | 2 | 0.0 |
Membrane Proteins/immunology/*metabolism | 2 | 7.0 |
Tumor Cells, Cultured | 35 | 0.0 |
Hepatitis C/*virology | 2 | 40.0 |
Liver Neoplasms | 2 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Antigens, CD/metabolism | 20 | 2.0 |
Cell Adhesion | 3 | 0.0 |
Comparative Study | 12 | 0.0 |
DNA, Neoplasm/analysis | 2 | 0.0 |
DNA, Viral/analysis | 2 | 0.0 |
Lymphocyte Activation | 11 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
T-Lymphocytes/immunology | 4 | 0.0 |
Antigens, CD/genetics/*metabolism | 5 | 5.0 |
Cloning, Molecular | 3 | 0.0 |
Ligands | 6 | 0.0 |
Membrane Glycoproteins/genetics/metabolism | 3 | 3.0 |
Mice | 41 | 0.0 |
Protein Binding | 27 | 0.0 |
Base Sequence | 16 | 0.0 |
DNA, Complementary/analysis | 2 | 0.0 |
Models, Biological | 3 | 0.0 |
RNA, Viral/analysis | 4 | 1.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Viral Envelope Proteins/metabolism | 9 | 17.0 |
Antigens, CD/*metabolism | 25 | 4.0 |
Cytotoxicity, Immunologic | 2 | 0.0 |
Immunologic Capping | 3 | 6.0 |
Interleukin-2/immunology | 3 | 2.0 |
Killer Cells, Natural/*immunology | 2 | 0.0 |
Receptors, Virus/*metabolism | 3 | 3.0 |
Viral Envelope Proteins/*metabolism | 6 | 13.0 |
Protein-Tyrosine Kinase/metabolism | 4 | 0.0 |
Signal Transduction | 5 | 0.0 |
Viral Envelope Proteins/*immunology | 2 | 5.0 |
COS Cells | 7 | 0.0 |
Cercopithecus aethiops | 7 | 0.0 |
Epitope Mapping | 2 | 0.0 |
Hepacivirus/immunology/*metabolism | 3 | 75.0 |
Membrane Proteins/metabolism | 10 | 1.0 |
Receptors, Virus/metabolism | 6 | 9.0 |
Virion/metabolism | 2 | 5.0 |
*Antigens, CD | 4 | 0.0 |
Integrins/chemistry/metabolism | 2 | 66.0 |
Neoplasm Metastasis/genetics | 2 | 4.0 |
Protein Conformation | 11 | 0.0 |
*Proto-Oncogene Proteins | 13 | 0.0 |
Sequence Alignment | 7 | 0.0 |
Cell Movement | 5 | 0.0 |
Coculture Techniques | 4 | 0.0 |
Dyes | 2 | 1.0 |
Fluorescent Antibody Technique | 6 | 0.0 |
Microscopy, Confocal | 5 | 0.0 |
Antigens, CD/biosynthesis | 2 | 0.0 |
Cell Line, Tumor | 8 | 0.0 |
Cytoplasm/metabolism | 3 | 0.0 |
Gangliosides/biosynthesis/immunology | 2 | 100.0 |
Infant | 3 | 0.0 |
Membrane Glycoproteins/biosynthesis | 2 | 1.0 |
Sensitivity and Specificity | 2 | 0.0 |
Antigens, CD/physiology | 3 | 1.0 |
Hepacivirus/genetics/*pathogenicity/physiology | 3 | 60.0 |
Mutation | 4 | 0.0 |
Pan troglodytes | 2 | 1.0 |
Receptors, LDL/physiology | 2 | 11.0 |
Receptors, Virus/*physiology | 4 | 10.0 |
Recombinant Proteins/metabolism | 4 | 0.0 |
Variation (Genetics) | 2 | 0.0 |
Antigens, CD/*physiology | 9 | 2.0 |
Mice, Inbred BALB C | 9 | 0.0 |
Mice, Inbred C57BL | 7 | 0.0 |
Molecular Weight | 2 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
*Virus Replication | 2 | 0.0 |
Fetus | 2 | 0.0 |
Antigens, CD/chemistry/*metabolism | 3 | 7.0 |
Hepacivirus/*metabolism | 5 | 35.0 |
Protein Transport | 2 | 0.0 |
DNA Primers | 4 | 0.0 |
Sequence Homology, Amino Acid | 8 | 0.0 |
Integrin alpha3beta1 | 9 | 29.0 |
Integrins/*metabolism | 7 | 4.0 |
Membrane Proteins/*metabolism | 10 | 2.0 |
Mutagenesis | 3 | 0.0 |
Antibodies, Monoclonal | 10 | 0.0 |
Genetic Vectors | 3 | 0.0 |
Viral Proteins/immunology | 3 | 10.0 |
*Antigens, Neoplasm | 3 | 1.0 |
Mice, Transgenic | 3 | 0.0 |
Antiviral Agents/*therapeutic use | 3 | 2.0 |
Down-Regulation | 4 | 0.0 |
Antigens, CD/*biosynthesis | 4 | 2.0 |
Cell Differentiation | 5 | 0.0 |
Immunophenotyping | 4 | 0.0 |
Antigens, CD/genetics | 3 | 2.0 |
Antigens, CD29/*metabolism | 4 | 10.0 |
Blotting, Western | 5 | 0.0 |
Enzyme Activation | 2 | 0.0 |
Integrin alpha6beta1 | 4 | 21.0 |
Jurkat Cells | 4 | 0.0 |
Protein Kinase C/*metabolism | 2 | 0.0 |
Antibody Affinity | 4 | 2.0 |
Cross Reactions | 2 | 0.0 |
Hydrogen-Ion Concentration | 4 | 0.0 |
Neutralization Tests | 3 | 0.0 |
Protein Structure, Tertiary | 9 | 0.0 |
Sequence Deletion | 2 | 0.0 |
Viral Envelope Proteins/*chemistry/genetics/immunology/*metabolism | 2 | 100.0 |
Antigens, CD/*genetics | 6 | 2.0 |
Membrane Glycoproteins/*genetics | 3 | 0.0 |
Antigens, CD/metabolism/*physiology | 2 | 7.0 |
Antigens, CD98 | 3 | 27.0 |
Rats | 7 | 0.0 |
Structure-Activity Relationship | 5 | 0.0 |
Antigens, CD/*chemistry | 2 | 7.0 |
Cross-Linking Reagents/pharmacology | 2 | 1.0 |
Fluorescent Antibody Technique, Indirect | 3 | 0.0 |
Membrane Proteins/chemistry | 2 | 4.0 |
Plasmids/metabolism | 2 | 0.0 |
Spectrum Analysis, Mass | 2 | 0.0 |
B-Lymphocytes/virology | 2 | 15.0 |
*Mutation | 2 | 0.0 |
Up-Regulation | 3 | 0.0 |
Viral Envelope Proteins/*genetics | 2 | 6.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 8 | 0.0 |
T-Lymphocytes/*immunology | 4 | 0.0 |
Antigens, CD/*chemistry/physiology | 2 | 28.0 |
Crystallography, X-Ray | 2 | 0.0 |
Models, Molecular | 3 | 0.0 |
Protein Structure, Secondary | 2 | 0.0 |
Recombinant Proteins/chemistry | 3 | 0.0 |
*Cell Adhesion | 3 | 1.0 |
Cell Membrane/metabolism | 6 | 0.0 |
Chromatography, Affinity | 2 | 0.0 |
Integrins/metabolism/*physiology | 2 | 25.0 |
Membrane Proteins/metabolism/*physiology | 4 | 12.0 |
Cytokines/biosynthesis | 3 | 0.0 |
Interleukin-2/pharmacology | 2 | 0.0 |
*Lymphocyte Activation | 2 | 0.0 |
Viral Envelope Proteins/*physiology | 2 | 11.0 |
Chromosomes, Human, Pair 11/*genetics | 2 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Antigens, CD3/immunology | 2 | 0.0 |
Lymphocyte Activation/*immunology | 3 | 0.0 |
Receptors, Antigen, T-Cell, gamma-delta/*immunology | 2 | 4.0 |
Cell Differentiation/immunology | 3 | 0.0 |
Platelet Membrane Glycoproteins/metabolism | 2 | 2.0 |
Hepacivirus/*physiology | 9 | 42.0 |
Immunohistochemistry | 7 | 0.0 |
Hepatocytes/*virology | 2 | 66.0 |
Lymphocytes/virology | 3 | 15.0 |
Organ Specificity | 2 | 0.0 |
Viral Envelope Proteins/chemistry/genetics/*metabolism | 2 | 28.0 |
Antibodies, Viral/immunology | 2 | 2.0 |
Binding Sites | 10 | 0.0 |
Glycosylation | 4 | 0.0 |
Solubility | 4 | 0.0 |
Rats, Wistar | 2 | 0.0 |
Time Factors | 3 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 3 | 0.0 |
Antibodies/immunology | 3 | 0.0 |
Antigens, CD/genetics/metabolism | 2 | 3.0 |
Gene Expression | 7 | 0.0 |
Hepacivirus/genetics/*metabolism | 3 | 30.0 |
Recombinant Fusion Proteins/genetics/metabolism | 5 | 0.0 |
Antigens, CD/chemistry/genetics/*metabolism | 3 | 10.0 |
Protein Processing, Post-Translational | 3 | 0.0 |
Drug Design | 2 | 0.0 |
Endoplasmic Reticulum/metabolism | 3 | 1.0 |
Cell Separation | 3 | 0.0 |
Infant, Newborn | 4 | 0.0 |
Membrane Proteins/genetics/*metabolism | 3 | 1.0 |
Viral Envelope Proteins/genetics/*metabolism | 3 | 11.0 |
Cell Adhesion Molecules/metabolism | 2 | 0.0 |
Antigens, CD/immunology | 3 | 0.0 |
Membrane Proteins/immunology | 3 | 5.0 |
B-Lymphocytes/immunology | 2 | 0.0 |
Antigens, CD/*chemistry/metabolism | 2 | 20.0 |
Heparin/*metabolism | 2 | 2.0 |
L Cells (Cell Line) | 3 | 1.0 |
Membrane Glycoproteins/metabolism | 6 | 1.0 |
Vero Cells | 2 | 0.0 |
Antigens, CD/*analysis | 3 | 0.0 |
*Flow Cytometry | 2 | 1.0 |
Virus Replication | 2 | 0.0 |
Cell Line, Transformed | 4 | 0.0 |
Cell Communication | 2 | 0.0 |
Antigens, CD/genetics/immunology/*metabolism | 2 | 12.0 |
*Signal Transduction | 5 | 0.0 |
Membrane Glycoproteins/*metabolism | 4 | 0.0 |
Cell Fusion | 2 | 0.0 |
English Abstract | 2 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Cell Adhesion/immunology | 2 | 1.0 |
Cell Division/physiology | 2 | 0.0 |
Antigens, CD/*chemistry/*metabolism | 2 | 25.0 |
Cross-Linking Reagents | 3 | 0.0 |
Membrane Microdomains/immunology/metabolism | 2 | 50.0 |
Palmitic Acid/*metabolism | 3 | 16.0 |
Recombinant Fusion Proteins/metabolism | 3 | 0.0 |
Viral Envelope Proteins/genetics/immunology/*metabolism | 2 | 28.0 |
Antigens, CD/analysis | 4 | 0.0 |
Energy Transfer | 2 | 3.0 |
Fluorescent Dyes | 2 | 0.0 |
Receptors, Interleukin-2/analysis | 2 | 0.0 |
Antibodies | 2 | 0.0 |
Receptors, IgG/biosynthesis | 2 | 7.0 |
Polymerase Chain Reaction | 5 | 0.0 |
B-Lymphocytes/*physiology | 2 | 1.0 |
HLA-D Antigens/metabolism | 2 | 11.0 |
Membrane Fusion/physiology | 2 | 11.0 |
*Down-Regulation | 2 | 0.0 |
Membrane Proteins/*physiology | 3 | 2.0 |
Dimerization | 5 | 0.0 |
*Endocytosis | 2 | 1.0 |
Membrane Glycoproteins/physiology | 2 | 1.0 |
DNA Primers/genetics | 2 | 0.0 |
Interleukin-2/biosynthesis | 2 | 0.0 |
Cell Culture Techniques | 2 | 0.0 |
Membrane Proteins/genetics/immunology/*metabolism | 2 | 20.0 |
Cell Communication/immunology | 3 | 3.0 |
Cell Movement/*physiology | 3 | 1.0 |
Malaria/*parasitology | 2 | 33.0 |
*Multigene Family | 2 | 0.0 |
Cell Membrane/immunology/metabolism | 2 | 1.0 |
Integrin alpha4beta1/*metabolism | 2 | 50.0 |
Antigens, CD4/metabolism | 2 | 0.0 |
B-Lymphocytes/*chemistry | 2 | 9.0 |
Antigen-Presenting Cells/immunology | 2 | 0.0 |
B-Lymphocytes/enzymology/immunology/*metabolism | 2 | 50.0 |
Drug Synergism | 2 | 0.0 |
Platelet Membrane Glycoproteins/*metabolism | 2 | 1.0 |
Cell Division/immunology | 4 | 1.0 |
Microscopy, Electron | 2 | 0.0 |
Antigens, CD2/metabolism | 2 | 7.0 |
CD4-Positive T-Lymphocytes/metabolism | 2 | 1.0 |
Antibodies/pharmacology | 3 | 0.0 |
Interferon Type II/pharmacology | 2 | 0.0 |
Kinetics | 2 | 0.0 |
Calcium/metabolism | 2 | 0.0 |
Virion/*metabolism | 2 | 9.0 |
Hepatocytes/metabolism | 2 | 2.0 |
NIH 3T3 Cells | 2 | 0.0 |
Hepatocytes/virology | 2 | 100.0 |
Signal Transduction/*physiology | 2 | 0.0 |
Immunoglobulins/*metabolism | 2 | 3.0 |
Integrins/metabolism | 2 | 1.0 |
Mice, Knockout | 4 | 0.0 |
Heparin/pharmacology | 2 | 0.0 |
Antigens, CD19/metabolism | 2 | 8.0 |
Genes, Reporter | 2 | 0.0 |
Receptors, CCR5/*metabolism | 2 | 1.0 |
Carcinoma, Hepatocellular | 2 | 0.0 |
Culture Media | 2 | 0.0 |
Inflammation Mediators/metabolism | 2 | 2.0 |